MedTrace Logo

Tiotropium Plus Olodaterol vs Inhaled Corticosteroids (ICS) Regimens in the Portuguese Primary Care Setting (TIOLCOR Study)

NCT04402515 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2021-11-05

No results posted yet for this study

Summary

What are the differences between patients prescribed a new maintenance treatment for Chronic Obstructive Pulmonary Disease (COPD) with tiotropium/olodaterol (TIO/OLO) or Inhaled Corticosteroids (ICS)-containing regimens in terms of sociodemographic, anthropometric and clinical characteristics?

Conditions

  • Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

TIO/OLO

Tiotropium/Olodaterol

DRUG

ICS

inhaled cortocosteroids

Sponsors & Collaborators

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-10-28
Primary Completion
2022-01-15
Completion
2022-01-31
FDA Drug
Yes

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04402515 on ClinicalTrials.gov